HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythroplasia of Queyrat: treatment with topical 5-fluorouracil.

Abstract
Seven adult men with biopsy-confirmed erythroplasia of Queyrat (EQ) were cured of their disease with topically applied 5-fluorouracil (5-FU) under occlusion. Post-treatment biopsy specimens revealed normal histologic findings and recurrence-free follow-up periods extended up to 70 months. It is suggested that topical 5-FU is the treatment of choice for histologically confirmed EQ because of its superior results compared with thoseof surgery or radiation therapy. Our view is corroborated by several single case reports of EQ similarly treated.
AuthorsD K Goette, T E Carson
JournalCancer (Cancer) Vol. 38 Issue 4 Pg. 1498-502 (Oct 1976) ISSN: 0008-543X [Print] United States
PMID991073 (Publication Type: Journal Article)
Chemical References
  • Fluorouracil
Topics
  • Administration, Topical
  • Adult
  • Aged
  • Carcinoma in Situ (drug therapy)
  • Carcinoma, Squamous Cell (drug therapy)
  • Erythroplasia (drug therapy)
  • Fluorouracil (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Penile Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: